Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Cervical Neoplasms × Pharmacogenomic Testing × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Malignant Tumor of Ill-defined Site 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1

Interventions

Cisplatin 28 human papillomavirus vaccine, L1 type 16, 18 16 Brachytherapy 13 Bevacizumab 11 Paclitaxel 10 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 10 Platinum 9 1,2-diaminocyclohexaneplatinum II citrate 9 Topotecan 8 Radiation 8 Papillomavirus Vaccines 8 Radiotherapy, Intensity-Modulated 7 pembrolizumab 6 Cyclophosphamide 6 tisotumab vedotin 5 fludarabine phosphate 5 fludarabine 5 aldesleukin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Gemcitabine 5 Fluorodeoxyglucose F18 5 Carboplatin 5 atezolizumab 4 Vaccines, Synthetic 4 Taxes 4 Nivolumab 4 Colposcopy 4 Tobacco Use Cessation Devices 3 Surveys and Questionnaires 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡